Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD [Phase 1]
The FREEDMM trial is a Phase 1 study investigating whether patients with multiple myeloma can discontinue maintenance therapy based on minim…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial evaluating a triplet regimen of isatuximab, carfilzomib, and pomalidomide for relapsed or refractory multip…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma [EARLY_Phase 1]
An early-phase clinical trial update exploring CAR-T cell therapy for multiple myeloma, with non-invasive monitoring of biodistribution usin…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients [Phase 3]
This document provides an update on a Phase 3 trial evaluating Motixafortide (BL-8040) with G-CSF for stem cell mobilization in multiple mye…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 clinical trial update evaluating belantamab mafodotin or daratumumab in combination with bortezomib, lenalidomide, and dexamethasone…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
This clinical trial update covers a Phase 2 study of daratumumab in newly diagnosed multiple myeloma. The study is currently active but not …
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment [Phase 2]
Phase 2 multicenter, non-blinded trial evaluating home self-administration of chemotherapy for multiple myeloma; currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Anonymization of Clinical Data From Pseudonymized Databases Collected as Part of Previus Clinical Trials on Multiple Myeloma
A clinical trial is updating practices around anonymizing data from pseudonymized databases collected in prior multiple myeloma trials.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a combination of elotuzumab, iberdomide, and dexamethasone after idecabtagene vicleucel (ide-cel) i…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors [Phase 1]
Phase 1 study assessing a subcutaneous formulation of TQB2934 for injection in subjects with malignant plasma cell tumors, including multipl…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Plan Development for Giving Teclistamab in the Outpatient Setting [Phase 4]
Plan development for delivering teclistamab to patients with relapsed/refractory multiple myeloma in the outpatient setting as part of a Pha…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
A registry study to evaluate cancer and aging resilience in older adults with hematologic malignancies, including multiple myeloma, amyloido…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001) [Phase 1]
Update on the Phase 1 study of HPN217 (MK-4002-001) for relapsed/refractory multiple myeloma, indicating the trial remains active but not re…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma [Phase 3]
This is a Phase 3 clinical trial comparing Selinexor, Pomalidomide, and Dexamethasone (SPd) against Elotuzumab, Pomalidomide, and Dexamethas…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating LBL-034 in patients with relapsed/refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients [Phase 1]
This is a Phase I study evaluating conditioning with bendamustine and melphalan followed by autologous stem cell transplantation for elderly…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma
A completed clinical trial update examining patient experiences and treatment preferences for multiple myeloma.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma [Phase 2]
A Phase 2 trial evaluating elranatamab in patients with clinically high-risk relapsed multiple myeloma after cilta-cel; the study is current…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy [Phase 2]
Phase II trials are evaluating letermovir prophylaxis in relapsed/refractory multiple myeloma patients receiving elranatamab, with recruitme…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA [Phase 4]
A Phase 4 clinical trial update from the University of Turin comparing two standard treatments for multiple myeloma in patients ineligible f…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: European Myeloma Network (EMN) Sample Project
A European Myeloma Network study evaluating treatment options for multiple myeloma and related plasma cell disorders is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma [NA]
Clinical trial update shows a study evaluating early palliative care for patients with multiple myeloma and aggressive lymphoma is currently…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating mezigdomide in combination with elranatamab for relapsed/refractory multiple myeloma; the study …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
This document reports a prospective observational study called PREAMBLE in multiple myeloma. It is sponsored by Bristol-Myers Squibb and is …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma [Phase 2]
Phase 2 clinical trial assessing lenalidomide and CC-486 with radiation therapy in patients with plasmacytoma; the study is currently active…